Skip to content

Insider · CIK 0001673237

Grant Julie Papanek

Reports to the SEC for 2 companies · MILPITAS, CA

Transactions

50

Companies

2

Filings

9

CIK

0001673237

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2023-03-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$465K
2023-02-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$507K
2023-02-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$24K
2023-01-03DAWNDay One Biopharmaceuticals, Inc.S Sale−$354K
2023-01-03DAWNDay One Biopharmaceuticals, Inc.S Sale−$162K
2022-12-08DAWNDay One Biopharmaceuticals, Inc.S Sale−$96.2K
2022-12-02DAWNDay One Biopharmaceuticals, Inc.S Sale−$108K
2022-12-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$5,361
2022-12-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$103K
2022-11-02DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-11-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-10-04DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-10-03DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-09-21DAWNDay One Biopharmaceuticals, Inc.S Sale−$118K
2022-09-21DAWNDay One Biopharmaceuticals, Inc.J Other—
2022-09-21DAWNDay One Biopharmaceuticals, Inc.S Sale−$11.3M
2022-09-20DAWNDay One Biopharmaceuticals, Inc.S Sale−$2.85M
2022-09-20DAWNDay One Biopharmaceuticals, Inc.S Sale−$45.5K
2022-09-19DAWNDay One Biopharmaceuticals, Inc.S Sale−$1.58M
2022-09-16DAWNDay One Biopharmaceuticals, Inc.S Sale−$2.4M
2022-09-16DAWNDay One Biopharmaceuticals, Inc.S Sale−$82K
2022-09-15DAWNDay One Biopharmaceuticals, Inc.S Sale−$1.09M
2022-09-15DAWNDay One Biopharmaceuticals, Inc.S Sale−$78.6K
2022-09-14DAWNDay One Biopharmaceuticals, Inc.S Sale−$9,327.36
2022-09-14DAWNDay One Biopharmaceuticals, Inc.S Sale−$2.5M
2022-09-13DAWNDay One Biopharmaceuticals, Inc.S Sale−$25.1K
2022-09-13DAWNDay One Biopharmaceuticals, Inc.S Sale−$2.11M
2022-09-02DAWNDay One Biopharmaceuticals, Inc.S Sale−$119K
2022-09-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$104K
2022-09-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$12.6K
2022-08-05DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-08-04DAWNDay One Biopharmaceuticals, Inc.S Sale−$100K
2022-07-18DAWNDay One Biopharmaceuticals, Inc.S Sale−$52K
2022-07-08DAWNDay One Biopharmaceuticals, Inc.S Sale−$24.8K
2022-07-05DAWNDay One Biopharmaceuticals, Inc.S Sale−$16K
2022-07-05DAWNDay One Biopharmaceuticals, Inc.S Sale−$16K
2022-07-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$20K
2022-07-01DAWNDay One Biopharmaceuticals, Inc.S Sale−$20K
2022-06-21DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award—
2021-11-03DAWNDay One Biopharmaceuticals, Inc.G Gift—
2021-11-03DAWNDay One Biopharmaceuticals, Inc.G Gift—
2021-06-01DAWNDay One Biopharmaceuticals, Inc. · Series A Preferred StockC Conversion—
2021-06-01DAWNDay One Biopharmaceuticals, Inc.C Conversion—
2021-06-01DAWNDay One Biopharmaceuticals, Inc.P Purchase+$208K
2021-06-01DAWNDay One Biopharmaceuticals, Inc. · Series B Preferred StockC Conversion—
2021-06-01DAWNDay One Biopharmaceuticals, Inc.C Conversion—
2021-05-26DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award—
2021-02-01DAWNDay One Biopharmaceuticals, Inc. · Series B Preferred StockA Award—
2017-05-25PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award—
2016-09-13PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award—

Recent filings

9

Companies

2

Address

C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100

MILPITAS, CA, 95035